𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The cost and availability of therapeutic options in advanced prostatic carcinoma in Turkey

✍ Scribed by N. Y. Ilker; Ö. Dillioĝlugil; A. Akda§

Book ID
110552608
Publisher
Springer Netherlands
Year
1992
Tongue
English
Weight
154 KB
Volume
24
Category
Article
ISSN
0301-1623

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression, structure, and function of a
Expression, structure, and function of androgen receptor in advanced prostatic carcinoma
✍ Culig, Zoran; Hobisch, Alfred; Hittmair, Anton; Peterziel, Heike; Cato, Andrew C 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB 👁 2 views

## BACKGROUND. Endocrine therapy for prostate cancer aims to reduce the levels of circulating androgen or to inhibit androgen action by blocking the androgen receptor in the prostate, or both. Studies in various animal and human prostate cancer models suggested that there may be a downregulation o

Pharmacokinetics of Anandron in patients
Pharmacokinetics of Anandron in patients with advanced carcinoma of the prostate
✍ Lakshmi Pendyala; Patrick J. Creaven; Robert Huben; Dominique Tremblay; Christin 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 716 KB

The pharmacokinetics of total radioactivity and unchanged drug were studied in patients receiving Anandron (Nilutamide, RU 23908) after a single dose of [14C] Anandron and after q12 h dosings of unlabelled drug for 2-7 weeks. The results indicate that the radioactivity in plasma consists of unchange